Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-12

Clinical Trial Update: Probiotic Blend for Celiac Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a probiotic blend aimed at treating Celiac Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude | Conditions: Celiac Disease | Phase 2 | Status: UNKNOWN